XWELL (XWEL) Projected to Release Earnings on Wednesday

XWELL (NASDAQ:XWEL) is expected to be posting its Q3 2026 results on Wednesday, November 18th. Analysts expect the company to post earnings of ($1.00) per share and revenue of $2.37 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Friday, November 20, 2026 at 4:00 PM ET.

XWELL (NASDAQ:XWEL) last posted its earnings results on Friday, August 14th. The company reported ($0.26) EPS for the quarter, topping the consensus estimate of ($1.00) by $0.74. The business had revenue of $7.15 million during the quarter, compared to analysts’ expectations of $2.37 million. XWELL had a negative return on equity of 1,091.48% and a negative net margin of 82.90%.

XWELL Stock Down 4.1%

Shares of NASDAQ XWEL opened at $0.54 on Wednesday. The stock’s 50-day simple moving average is $0.81 and its two-hundred day simple moving average is $1.00. XWELL has a twelve month low of $0.26 and a twelve month high of $2.20. The firm has a market capitalization of $5.71 million, a P/E ratio of -0.10 and a beta of 1.04.

Analyst Ratings Changes

Separately, Weiss Ratings raised XWELL from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, November 3rd. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

XWELL Company Profile

XWELL Corp. (NASDAQ:XWEL) is a health and wellness services company focused on providing convenient, consumer-oriented care in travel and other high-traffic environments. The company is best known for XpresSpa, a wellness brand that offers services such as massages, facials, nail care and related relaxation treatments, primarily at airports. The company was formerly known as XpresSpa Group and changed its name to XWELL in 2023 to reflect a broader focus on wellness and health-related services. During the COVID-19 pandemic, the company expanded into health screening and testing through its XpresCheck business.